Medivation Gets $110M Upfront From Astellas In Prostate Cancer Collaboration
This article was originally published in The Pink Sheet Daily
Executive Summary
As in its Dimebon collaboration with Pfizer, the biotech gets significant U.S. profit-sharing along with an option for co-promotion.